Organization · Venture Capital
Partnology
Partnology is a biotech growth and investment firm based in Southern California, specializing in seed-stage investments and executive search services for early-stage biotech companies. Founded in 2019, it focuses on assembling exceptional teams and supporting innovative ventures.
Overview
What Partnology does
What Partnology is
Partnology is a biotech growth and investment firm based in Southern California, specializing in seed-stage investments and executive search services for early-stage biotech companies. Founded in 2019, it focuses on assembling exceptional teams and supporting innovative ventures.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find Partnology elsewhere
Open the official website or a supported primary organization account.
Capability profile
Partnology as a funder
Investment thesis
Partnology focuses on seed investing in biotech companies that aim to create innovative therapies for underserved patient populations, combining capital with executive search and company-building expertise.
Focus narrative
Partnology invests in early-stage biotech companies, particularly those that aim to address underserved patient populations. The firm combines capital investment with expertise in executive search and company building, leveraging a network of venture firms, strategic investors, and industry professionals to support the growth of its portfolio companies.
Value beyond capital
Partnology adds value to its portfolio companies by providing not only capital but also expertise in executive search and company building. The firm helps founders assemble exceptional teams and connects them with a network of investors and industry professionals, enhancing their chances of success in the competitive biotech landscape.
Focus and fit
- Stages
- Pre-seed · Seed
- Sectors
- Biotech & Life Sciences
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Partnology's portfolio includes notable biotech companies such as Capacity Bio, which focuses on mitochondrial biology and mitophagy; EpiTET Therapeutics, which develops molecular-glue therapeutics targeting pathogenic macrophages in chronic inflammation; and MBrace Therapeutics, a clinical-stage ADC company working on novel cancer therapeutics.
Common questions
What to know about Partnology
Upseed classifies Partnology under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.